Clinical Trials

Study Title:
A Phase III, Single Arm Study to Evaluate the Efficacy and Safety of ONCOFID P B (paclitaxel hyaluronic acid conjugate) Administered Intravesically to Patients with BCG unresponsive Carcinoma in Situ of the Bladder with or without Ta T1 Papillary Disease

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Stephen Savage, at savages@musc.edu. Study Coordinator, Renee Tucker, at tuckerr@musc.edu. Trial opened at the following institutions: Medical University of South Carolina